Buscarinu, M.C.; Fornasiero, A.; Pellicciari, G.; Reniè, R.; Landi, A.C.; Bozzao, A.; Cappelletti, C.; Bernasconi, P.; Ristori, G.; Salvetti, M.
Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab Treatment. Brain Sci. 2019, 9, 299.
https://doi.org/10.3390/brainsci9110299
AMA Style
Buscarinu MC, Fornasiero A, Pellicciari G, Reniè R, Landi AC, Bozzao A, Cappelletti C, Bernasconi P, Ristori G, Salvetti M.
Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab Treatment. Brain Sciences. 2019; 9(11):299.
https://doi.org/10.3390/brainsci9110299
Chicago/Turabian Style
Buscarinu, Maria Chiara, Arianna Fornasiero, Giulia Pellicciari, Roberta Reniè, Anna Chiara Landi, Alessandro Bozzao, Cristina Cappelletti, Pia Bernasconi, Giovanni Ristori, and Marco Salvetti.
2019. "Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab Treatment" Brain Sciences 9, no. 11: 299.
https://doi.org/10.3390/brainsci9110299
APA Style
Buscarinu, M. C., Fornasiero, A., Pellicciari, G., Reniè, R., Landi, A. C., Bozzao, A., Cappelletti, C., Bernasconi, P., Ristori, G., & Salvetti, M.
(2019). Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab Treatment. Brain Sciences, 9(11), 299.
https://doi.org/10.3390/brainsci9110299